We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation.
Our established group of experienced scientists is based at our fully-equipped research laboratories on Granta Park, Cambridge UK. We integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive medicinal chemistry expertise to enable drug discovery on both established and novel targets. We have the experience and capabilities for progressing projects from target identification through to clinical candidate. We have generated lead compounds on kinases, ATPases, protein-protein interactions and GPCRs, leading to clinical candidates for Chk1, Hsp90, Bcl-2, Mcl-1, FAAH and A2A.
We balance an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical companies and academic partners. Our shared-risk approach ensures a high level of engagement from our scientists and rewards success. Current disclosed collaborations include those with Servier, Daiichi Sankyo, Lundbeck and Asahi Kasei Pharma, and we seek additional partnerships.
Company Details
- Employees
- 242
- Founded
- -
- Address
- Granta Park, Great Abington,united Kingdom
- Phone
- +44 118 977 3133
- me****@****lis.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vernalis.com
- Keywords
- drug discovery, FBLD, structure-based, oncology, structural biology, biophysics, assay technology, medicinal chemistry, molecular modelling, protein engineering, NMR, X-Ray crystallography, DMPK, synthetic organic chemistry, cheminformatics, SPR, ITC, drug development, CNS, Cell biology.
- HQ
- Cambridge, Cambs
Vernalis Questions
Vernalis's helpline number is +44 118 977 3133
Vernalis's website is vernalis.com
Vernalis's LinkedIn profile is https://uk.linkedin.com/company/vernalis
Vernalis has
242 employees.
View email and phone details for 242
employees at Vernalis.
Vernalis's industry is
Biotechnology Research
Vernalis's top competitors are
Nxera Pharma,
Astex Pharmaceuticals,
Domainex,
Artios,
Scorpion Therapeutics,
Amphista Therapeutics Limited,
Bicycle Therapeutics,
Hitgen Inc.,
Vernalis Consulting,
Abiosciences.
Vernalis's support email address is medical@vernalis.com
Vernalis's categories are Biotechnology Research
Vernalis's founding year is 1997
